Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
- Conditions
- Pre Diabetes
- Interventions
- Other: Digital diabetes prevention program (dDPP)Other: Adapted dDPP-EHR tool
- Registration Number
- NCT04773834
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the dDPP application. The system is designed to minimize work for providers by sending automated targeted messages to patients to potentially increase engagement, prevent onset of diabetes and improve clinical outcomes. The patients in the study are automatically nudged using a combination of text messaging and MyChart messaging.
- Detailed Description
Using a mixed-methods design, this study will be completed in three phases. For Phase 3, we aim to conduct a randomized control trial with 400 patients with pre-diabetic, all of whom will be using the dDPP application. Half of enrolled patients will be randomized to the intervention group and receive automated targeted messaging.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 490
- 18 years or older, BMI ≥ 25 kg/m2 (> 22 kg/m2 if self-identified as Asian)
- Must be a NYU Langone patient
- A diagnosis of prediabetes (either diagnosis of prediabetes or an HbA1C level of 5.7%-6.4% in past 12 months) or diabetes risk factors (BMI ≥ 25 kg/m2 or > 22 kg/m2 if self-identified as Asian
- Safe to engage in moderate physical exercise (as determined by their PCP)
- Sufficient English to be able to complete the enrollment process
- Has app-capable device with data to use the dDPP application and receive text messages
- Diagnosed with diabetes
- Patients whose weight may vary considerably over the study's timeframe for reasons other than the intervention (e.g. cancer, pregnancy, ascites, severe CHF)
- Patients with severe psychiatric disease or dementia
- Active health condition that prevents them from engaging in moderate exercise
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental group Adapted dDPP-EHR tool Participants will be enrolled virtually into a digital diabetes prevention program through the Noom app and willing to receive text messages based on their engagement levels in Noom from the study team, as well as complete text-based surveys. Control group Digital diabetes prevention program (dDPP) Participants will be enrolled virtually into the digital diabetes prevention program through the Noom app and willing to receive general text messages from the study team Experimental group Digital diabetes prevention program (dDPP) Participants will be enrolled virtually into a digital diabetes prevention program through the Noom app and willing to receive text messages based on their engagement levels in Noom from the study team, as well as complete text-based surveys.
- Primary Outcome Measures
Name Time Method Body Mass Index (BMI) (kg/m2) through completion of dDPP program (average 1 year) BMI will be calculated using height (m) from electronic health records and weight (kg) from remote Bluetooth-connected weight scales. Data will be collected at discrete time points: 0 month (at enrollment), 3 months, 6 months, 9 months, 12 months (study completion)
Hemoglobin A1c (HbA1c) level (mmol/mol) through completion of dDPP program (average 1 year) Repeated measurements of participant HbA1c will be taken via HbA1C home test kit and electronic health records. Data will be collected at discrete time points: 0 month (at enrollment), 6 months, 12 months (study completion)
Body Weight (kilograms) through completion of dDPP program (average 1 year) Repeated measurements of participant weight will be taken via remote Bluetooth-connected weight scales, measured in light clothing without shoes. Data will be collected at discrete time points: 0 month (at enrollment), 3 months, 6 months, 9 months, 12 months (study completion)
- Secondary Outcome Measures
Name Time Method dDPP platform user log-ins through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients measured using data on number of dDPP logins, as provided from the Noom platform
dDPP platform meal log (food item and calories/day) through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using data on number of completed meal logs, as provided from the Noom platform
dDPP platform lesson plans completed through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using the number of completion of weekly lesson plans, as provided from the Noom platform
dDPP platform group social posts sent through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using data on number of messages to online social groups, as provided from the Noom platform
dDPP platform step log (steps/day) through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using data on number of completed platform step logs, as provided from the Noom platform
dDPP platform coach messages sent through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using data on number of messages to coaches as provided from the Noom platform
dDPP platform exercise log (min) through completion of dDPP program (average 1 year) Perceptions of patient engagement will be collected via surveys from patients using data on number of completed platform exercise logs, as provided from the Noom platform
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States